Palisade Bio Inc. (PALI)
NASDAQ: PALI
· Real-Time Price · USD
0.68
0.05 (7.53%)
At close: Sep 24, 2025, 3:59 PM
0.68
-0.64%
After-hours: Sep 24, 2025, 07:57 PM EDT
7.53% (1D)
| Bid | 0.65 |
| Market Cap | 6.24M |
| Revenue (ttm) | 4K |
| Net Income (ttm) | -11.85M |
| EPS (ttm) | -3.64 |
| PE Ratio (ttm) | -0.19 |
| Forward PE | -0.51 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.69 |
| Volume | 1,404,766 |
| Avg. Volume (20D) | 2,374,609 |
| Open | 0.64 |
| Previous Close | 0.63 |
| Day's Range | 0.64 - 0.73 |
| 52-Week Range | 0.53 - 4.32 |
| Beta | 1.39 |
| Ex-Dividend Date | n/a |
About PALI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PALI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PALI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
-0.98%
PALI stock has given up its prior gain. Palisade B...
Unlock content with
Pro Subscription
2 weeks ago
-0.98%
Palisade Bio shares are trading higher after the company received Health Canada clearance to initiate a Phase 1b study of PALI-2108 in fibrostenotic Crohn's disease.
